These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 15808068)
1. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma]. Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068 [TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Shen Z; Wen XF; Lan F; Shen ZZ; Shao ZM Clin Cancer Res; 2002 Jul; 8(7):2085-90. PubMed ID: 12114407 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells]. Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010 [TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919 [TBL] [Abstract][Full Text] [Related]
5. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line]. Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Lu LJ; Liu G; Shen ZZ; Ding J; Shao ZM Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):389-92. PubMed ID: 16188119 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Li H; Weinstein IB Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886 [TBL] [Abstract][Full Text] [Related]
8. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Chen C; Chang YC; Liu CL; Chang KJ; Guo IC Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079 [TBL] [Abstract][Full Text] [Related]
9. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090 [TBL] [Abstract][Full Text] [Related]
10. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818 [TBL] [Abstract][Full Text] [Related]
11. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
12. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor]. Lin Y; Wang SM; Huang RP Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. Balasenthil S; Barnes CJ; Rayala SK; Kumar R FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330 [TBL] [Abstract][Full Text] [Related]
14. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099 [TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342 [TBL] [Abstract][Full Text] [Related]
17. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Lane J; Martin TA; Watkins G; Mansel RE; Jiang WG Int J Oncol; 2008 Sep; 33(3):585-93. PubMed ID: 18695890 [TBL] [Abstract][Full Text] [Related]
18. Physalis angulata induced G2/M phase arrest in human breast cancer cells. Hsieh WT; Huang KY; Lin HY; Chung JG Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
20. [Screening of a sub-clone of human breast cancer cells with high metastasis potential]. Ye LH; Wu LY; Guo W; Ma HT; Zhang XD Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]